Author Question: A patient receiving nedocromil (Tilade) asks how this drug will help control a respiratory ... (Read 34 times)

sam.t96 · **on:** Jul 23, 2018

A patient receiving nedocromil (Tilade) asks how this drug will help control a respiratory condi-tion. Which of the following responses would be most appropriate for the health care provider to give the patient?

a. It is a beta agonist that causes bronchodilation.
b. It stabilizes mast cells to block reaction to allergens.
c. It is a corticosteroid that suppresses the immune response.
d. It increases the diameter of the bronchioles.

Question 2

A patient with chronic respiratory disease has an order for salmeterol (Serevent), two puffs every 12 hours. Review the following possible adverse effects, and select the one that could occur fol-lowing a dose of this drug.

a. Pupil reaction
b. Heart rate changes
c. Deep tendon reflexes
d. Level of consciousness

mariahkathleeen · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: B
Nedocromil stabilizes mast cells, whereby the activation and release of chemical mediators from eosinophils and epithelial cells are blocked.

Answer to Question 2

ANS: B
Salmeterol xinafoate is a long-acting beta agonist commonly used in combination with an inhaled corticosteroid for long-term control of respiratory symptoms. Adverse effects include tachycardia and hypokalemia, and prolonged QT interval with overdose.